Juraj Adamik
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0002-3604-158XAlso affiliated with Parker Institute for Cancer Immunotherapy
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “Dysregulated NF-κB–Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma”.
Juraj Adamik, P.M.L. Santos, Jian Shi, Michael R. Shurin, John M. Kirkwood +3 more
Paul V. Munson, Felix J. Hartmann, Alexis J. Combes, Philippe Pierre, Matthew F. Krummel +4 more
Paul V. Munson, Deena M. Maurer, Felix J. Hartmann, Sean C. Bendall, Rafael J. Argüello +2 more
Juraj Adamik, Patricia M. Santos, Jian Shi, Michael R. Shurin, John M. Kirkwood +3 more
Juraj Adamik, Patricia M. Santos, Jian Shi, Michael R. Shurin, John M. Kirkwood +3 more
Juraj Adamik, Hongzhi Wang, Sharon E. Sember, Jennifer L. Muzzio, Mary Jo Buffo +6 more
Mary Jo Buffo, Cindy Sander, Sharon E. Sember, Hongzhi Wang, Juraj Adamik +6 more